论文部分内容阅读
Objective:Synthetic hydroxyapatite nanoparticles (HANPs) are widely used in nanomedicine fields.The delivery of nanomedicine to the bloodstream exposes the cardiovascular system to a potential threat.However, the possible adverse cardiovascular effects of HANPs remain unclear.